Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

A review published in Nutrients finds that ketogenic diets (KD) may offer superior benefits for weight loss, blood sugar ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...

The new tool allows doctors to input clinical data routinely collected on patients with diabetes to predict the most ...

A new study suggests that medications commonly used for diabetes, including the popular drug Ozempic, may help reduce the ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Currently, doctors do not treat breast cancer patients with obesity-driven diabetes any differently than those without ...

This innovative approach aims to improve blood glucose management and reduce the risk of serious complications.

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic retinal disease.

Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...